 |
 |
Referenzen (z.T. in abgekürzter Form) |
- James Broughton et al. (2020) CRISPR–Cas12-based detection of SARS-CoV-2. Nature Biotechnology 38: 870–874.
- Michael Terns et al. (2018) CRISPR-based Technologies: Impact of RNA-targeting Systems. Mol Cell 72: 404–412.
- Jennifer Rauch et al. (2020) Scalable Protocol for Cas13-Based Detection of SARS-CoV-2 RNA. bioRxiv 2020.04.052159.
- Yan Zhang et al. (2020) CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019. The CRISPR Journal 3: 140-142.
- Tuan Nguyen et al. (2020) Virus against virus: a potential treatment for SARS-CoV-2 and RNA viruses. Cell Research 30: 189–190.
- Timothy Abbott et al. (2020) Development of CRISPR as a Strategy to Combat SARS-CoV-2 and Influenza. Cell 181: 865–876.
- Lauren Dedow et al. (2019) Searching for a Match: Sequence-Specific RNA-Binding Proteins. Cell Physiology 60: 1927-1938.
- Rekha Jalandra et al. (2020) Strategies to develop SARS-CoV-2 diagnostics. Biomedicine & Pharmacotherapy 129: 110446.
- Ran Liu et al. (2020) Promising methods for detection of novel coronavirus SARS-CoV-2. VIEW 2020/1: e4.
- Sophie Mavrikou et al. (2020) Development of a Ultra-Rapid Cell-Based Biosensor for Detection of SARS-CoV-2. Sensors 20: 3121.
- David Nelles et al. (2016) Programmable RNA Tracking in Live Cells with CRISPR/Cas9. Cell 165: 488-496.
- Kazuo Takayama et al. (2020) In Vitro and Animal Models for SARS-CoV-2 research. Trends Pharmacol. Sciences 41: 513-516.
- Jiali Cao et al. (2019) Nanobody-based reporter for living cell sensing influenza A virus infection. Scientific Reports 9: 15899. |
|
|
|
